Effects of Prednisolone and Pentoxifylline on the Regulation of Urea Synthesis in Alcoholic Hepatitis
NCT01245257 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2016-09-12
Summary
Loss of total mass of muscles (catabolism) is a serious clinical problem in patients with alcoholic hepatitis. The liver might play an important role in this stress-catabolism by increasing the production of urea during the inflammatory process.
The purpose of this study is to examine the regulation of urea synthesis in patients with alcoholic hepatitis and to study the effect of the anti-inflammatory drugs prednisolone and pentoxifylline on this regulation.
Conditions
- Alcoholic Hepatitis
Sponsors & Collaborators
-
University of Aarhus
lead OTHER
Principal Investigators
-
Karen Louise Thomsen, MD · Aarhus University Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-11-30
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
Countries
- Denmark
Study Locations
More Related Trials
-
Oral Branched-chain Amino Acid Supplementation for Decompensated Cirrhotic Patients
NCT06121479 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Meta-Analysis of Drug Therapy in Patients With Severe Alcoholic Hepatitis
NCT02796469 ·Status: COMPLETED
-
Intensive Enteral Nutrition and Acute Alcoholic Hepatitis
NCT01801332 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition
NCT05011370 ·Status: COMPLETED
-
Short Course Steroids in Alcohol Associated Hepatitis
NCT06919458 ·Status: RECRUITING ·Phase: PHASE3
-
Double-blind Randomized Controlled Trial in Severe Alcoholic Hepatitis
NCT01214226 ·Status: COMPLETED ·Phase: PHASE3
-
Inflammation, Immune Activation and Portal Hypertension in Alcoholic Hepatitis
NCT00992888 ·Status: COMPLETED ·Phase: NA
-
Acute Liver Injury in Patients With Pneumonia
NCT06103981 ·Status: NOT_YET_RECRUITING
-
Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis
NCT04072822 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Induced Hyperammonaemia on Sleep and Melanopsin-mediated Pupillary Light Response in Patients With Liver Cirrhosis
NCT04771104 ·Status: COMPLETED ·Phase: NA
-
Plasma Free Amino Acids in Patients With Hepatic Encephalopathy
NCT03306498 ·Status: UNKNOWN
-
Effect of Alpha-1 Antitrypsin Supplementation on Alcohol-Associated Hepatitis
NCT06582329 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Sarcopenia and Cirrhosis
NCT02132962 ·Status: COMPLETED ·Phase: NA
-
Liver Disease in Urea Cycle Disorders
NCT04612764 ·Status: ACTIVE_NOT_RECRUITING
-
Nutritional Interventions in Patients With Alcohol-associated Hepatitis
NCT06131177 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Impact of Dietary Assessment and Intervention on Outcomes in Liver Cirrhosis Patients
NCT05259930 ·Status: RECRUITING ·Phase: NA
-
Efficacy Study of Anakinra, Pentoxifylline, and Zinc Compared to Methylprednisolone in Severe Acute Alcoholic Hepatitis
NCT01809132 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Corticosteroids in Alcoholic Hepatitis
NCT03160651 ·Status: UNKNOWN ·Phase: NA
-
Pentoxifylline for Acute Alcoholic Hepatitis (AAH)
NCT00205049 ·Status: TERMINATED ·Phase: PHASE1
-
Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects
NCT05249374 ·Status: COMPLETED ·Phase: PHASE1
-
Cerebral Oxygen, Blood Flow and Ammonia Uptake in Patients With Cirrhosis and an Acute Episode of Hepatic Encephalopathy (HE)
NCT01151475 ·Status: COMPLETED
-
Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?
NCT03368066 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Sodium Retention in Liver Cirrhosis With Dexamethasone
NCT01311167 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)
NCT04210245 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Non-alcoholic Fatty Liver Disease on Kidney Functions
NCT03172650 ·Status: UNKNOWN